Disciplined Investments’s Insmed INSM Stock Holding History

Disciplined Investments’s Portfolio INSM Stock Details INSM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-3	Closed	-$51	–	1708
2023 Q1	$51	Buy	+3	New	+$58	﹤0.01%	1632

Other funds holding INSM

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

PAI

Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Disciplined Investments's INSM Position: Q2 2023 in Review

Disciplined Investments sold out of Insmed (INSM) in Q2 2023, closing a stake of 3 shares — an estimated $51 sold.

Disciplined Investments first reported a position in INSM in Q1 2023 and held it in 1 quarter. The position peaked at $51 in Q1 2023. 223 funds tracked by Wall St. Rank hold INSM as of Q2 2023.

Disciplined Investments reported no remaining Insmed position as of Q2 2023 after selling out during the quarter.
Disciplined Investments sold 3 Insmed shares in Q2 2023, an estimated $51.
Disciplined Investments first reported a position in Insmed in Q1 2023 and held it in 1 quarter.
Disciplined Investments's Insmed position peaked at $51 in Q1 2023.
223 funds tracked by Wall St. Rank held Insmed as of Q2 2023.

Based on Disciplined Investments's 13F filing for Q2 2023, filed 10 Jul 2023.